May 11, 1999

 

NAME

 

ELDER PHARMACEUTICALS LIMITED

 

REGISTERED OFFICE

 

11-B Dhanraj Mahal, Apollo Bunder, Mumbai – 400 039, India.

Tel. No.      91-22-283 58 02 / 283 58 03 / 283 19 37

Fax No.      91-22-287 18 68

E-mail        elder@bom3.vsnl.net.in

 

FACTORY

 

1)                D-219 & D-220, T.T.C. Industrial Area, New Bombay – 400 706, India.

Tel. No.         91-22-767 23 43 / 768 58 03 / 768 33 13

Fax No.         91-22-768 59 87

 

2)                C-21/2, T.T.C. Industrial Area, Village : Pawne, Navi Mumbai – 400 704, India

 

BRANCH

 

Mumbai :

Prospect Chambers, 2nd Floor, D. N. Road, Mumbai – 400 001, India.

Tel. No.      91-22-204 32 57

 

Calcutta :

12-A Rani Bhawani Road, Raki House, Calcutta – 700 026, India.

Tel. No.      91-33-466 88 75 / 466 67 57

 

Chennai :

158 Arcot Road, II Floor, Eastern Wing, Chennai – 600 026, India.

Tel. No.      91-44-825 63 36 / 825 62 46 / 825 85 34

Fax No.      91-44-481 23 40

New Delhi :

S-56 Rajouri Garden, New Delhi – 110 027, India.

Tel. No.      91-11-546 89 27 / 546 92 21 / 512 37 15

Fax No.      91-11-546 57 57

 

HISTORY

 

The company was incorporated on 2nd April, 1983 at Mumbai in Maharashtra having Company Registration Number 29714.

 

LEGAL FORM

 

It is a Closely Held Public Limited Liability company.

 

DIRECTORS

 

Dr. K. Kalyan                          Chairman

Mr. J. Saxena                         Managing Director

Mr. M. V. Thomas                  Director (Finance)

Mr. V. J. Carrasco

Mr. Ajitkumar K. Hamlai

 

BUSINESS

 

The company is engaged in manufacturing and marketing of Pharmaceuticals in the form of Tablets, Capsules, Injectables, Ointments, Syrup / Liquids and Powder. The company’s production during the year 1996-97 was as under :

 

Class of Goods

Units

1996-97

1995-96

 

 

 

 

Tablets

Million

300.924

337.628

Capsules

Million

100.563

62.120

Injectables

Million

9.137

4.938

Ointments

Tonnes

3.086

1.687

Syrup / Liquids

Kilo Litres

27.799

30.164

Powders

Kgs.

9.680

78.200

 

The management states in its annual report for the period ended 31st March, 1997 that the company achieved a turnover of Rs.1,079.071 millions which was Rs.129.931 millions higher that the previous year marking an increase equivalent to 13.69% over the previous year. Inspite of better turnover the profit before and after tax was at a low figure of Rs.34.992 millions and Rs.25.992 millions respectively.

 

The company has entered into an agreement with the Chaudhary Group of Nepal for setting up a Join Venture company in Nepal. The said Joint Venture company, Chaudhary – Elder Laboratories Private Limited, has been established and has started the work of setting up a manufacturing unit for pharmaceutical formulations at Biratnagar in Nepal.

 

The company’s wholly owned subsidiary Jimp Capsule and Chemical Private Limited has been amalgamated with the company w.e.f. 1st January, 1996.

 

The company imports raw materials from Europe and Far East against L/C, D/A and D/P terms.

 

The company employs 300 persons.

 

ASSOCIATE COMPANIES

 

K                 Elder Health Care Limited

K                 Semit Pharmaceuticals & Chemicals Private Limited

K                 Akshaya Holdings Private Limited

 

BANKERS

 

K                 Union Bank of India, 66/80 Bombay Samachar Marg, Fort, Mumbai – 400 023, India

K                 ICICI Banking Corporation Limited, Free Press House, 215 Nariman Point, Mumbai – 400 021, India

 

AUDITORS

 

K                 S. S. Khandelwal & Company

          Chartered Accountants

Fountain Chambers, Nanabhai Lane, Mumbai – 400 023, India.

 

FINANCIAL INFORMATION

 

The company’s last available financial information for the period ended 31st March, 1997 is enclosed herewith.

 


CAPITAL STRUCTURE

 

Authorised Capital :

1,00,00,000 Equity Shares of Rs.10/- each                :  Rs.100.000 millions

 

Issued, Subscribed & Paid-up Capital :

61,14,454 Equity Shares of Rs.10/- each                  :  Rs.61.145 millions

 

COMMENTS

 

Subject is a well-established pharmaceutical company having satisfactory track. Directors are reported as experienced, respectable and having satisfactory means of their own. Payments are reported as slow but correct.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

**********************

 

IMPORTANT FINANCIAL INFORMATION FOR TWO PERIODS

[figures are in Rupees Millions]

 

PARTICULARS

31.03.1997

31.03.1996

 

 

 

Sales Turnover [including other income]

1,074.225

949.140

 

 

 

Profit/(Loss) Before Tax

34.992

50.321

Provision for Taxation

9.000

8.000

Profit/(Loss) After Tax

25.992

42.321

 

 

 

Earnings in Foreign Currency :

 

 

Export Earnings

76.482

106.202

 

 

 

Imports :

 

 

Raw Materials

155.655

165.161

 


ABRIDGED BALANCE SHEET AS ON 31ST MARCH, 1997

[figures are in Rupees Millions]

 

SOURCES OF FUNDS

31.03.1997

31.03.1996

 

 

 

SHAREHOLDERS FUNDS

 

 

1]  Share Capital

61.145

61.145

2] Reserves & Surplus

235.161

217.319

 

 

 

LOAN FUNDS

 

 

1] Secured Loans

341.681

307.750

2] Unsecured Loans

112.000

72.142

 

 

 

GRAND TOTAL

749.987

658.356

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

FIXED ASSETS [Net Block]

157.875

146.820

Capital work-in-progress

12.616

3.678

 

 

 

INVESTMENTS

10.294

12.294

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

Inventories

380.685

330.770

Sundry Debtors

232.008

209.984

Cash & Bank Balances

32.325

28.441

Other Current Assets

7.418

5.361

Loans & Advances

133.413

145.109

Total Current Assets

785.849

719.665

Less :

 

 

Current Liabilities

201.434

212.217

Provisions

23.726

22.526

Net Current Assets

560.689

484.922

 

 

 

MISCELLANEOUS EXPENDITURE

[to the extent not written off or adjusted]

8.513

10.642

 

 

 

GRAND TOTAL

749.987

658.356